Prognostic significance of MyD88L265P and CD79B mutations in primary central nervous system lymphoma
Clinical Research|更新时间:2024-02-08
|
Prognostic significance of MyD88L265P and CD79B mutations in primary central nervous system lymphoma
Medical Journal of Chinese People′s Liberation ArmyVol. 49, Issue 1, Pages: 57-63(2024)
作者机构:
兰州大学第二医院血液科,甘肃兰州 730030
作者简介:
E-mail: wuchy0909@163.com
基金信息:
the National Natural Science Foundation of China(8226010026);the Project of "Cuiying Graduate Instructor" Training in the Second Hospital of Lanzhou University(201710)
Jiang Hao-Yun,Jin Qi-Qi,Zhang Li-Tian,et al.Prognostic significance of MyD88L265P and CD79B mutations in primary central nervous system lymphoma[J].Medical Journal of Chinese People′s Liberation Army,2024,49(01):57-63.
Jiang Hao-Yun,Jin Qi-Qi,Zhang Li-Tian,et al.Prognostic significance of MyD88L265P and CD79B mutations in primary central nervous system lymphoma[J].Medical Journal of Chinese People′s Liberation Army,2024,49(01):57-63. DOI: 10.11855/j.issn.0577-7402.1223.2023.0528.
Prognostic significance of MyD88L265P and CD79B mutations in primary central nervous system lymphoma